NASDAQ:EDAP - Edap Tms Stock Price, Forecast & News

Edap Tms trades on the NASDAQ under the ticker symbol "EDAP."

Edap Tms SA (NASDAQ:EDAP) released its earnings results on Wednesday, November, 13th. The medical equipment provider reported $0.03 EPS for the quarter, missing the Thomson Reuters' consensus estimate of $0.04 by $0.01. The medical equipment provider earned $11.35 million during the quarter, compared to the consensus estimate of $13.15 million. Edap Tms had a net margin of 7.61% and a return on equity of 40.29%. View Edap Tms' Earnings History.

Edap Tms is scheduled to release their next quarterly earnings announcement on Monday, April 6th 2020. View Earnings Estimates for Edap Tms.

1 Wall Street analysts have issued twelve-month price objectives for Edap Tms' stock. Their forecasts range from $6.50 to $6.50. On average, they expect Edap Tms' stock price to reach $6.50 in the next year. This suggests a possible upside of 49.4% from the stock's current price. View Analyst Price Targets for Edap Tms.

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Edap Tms in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Edap Tms.

News headlines about EDAP stock have been trending neutral on Tuesday, InfoTrie Sentiment reports. The research group scores the sentiment of press coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Edap Tms earned a daily sentiment score of 0.4 on InfoTrie's scale. They also assigned media headlines about the medical equipment provider a news buzz of 9.0 out of 10, indicating that recent press coverage is extremely likely to have an effect on the company's share price in the immediate future. View News Stories for Edap Tms.

Edap Tms saw a decline in short interest in January. As of January 31st, there was short interest totalling 160,800 shares, a decline of 17.2% from the January 15th total of 194,300 shares. Based on an average daily volume of 146,900 shares, the short-interest ratio is currently 1.1 days. Currently, 0.6% of the shares of the stock are short sold. View Edap Tms' Current Options Chain.

Some companies that are related to Edap Tms include Zynex (ZYXI), TransMedics Group (TMDX), Cutera (CUTR), Semler Scientific (SMLR), Viewray (VRAY), BioLife Solutions (BLFS), Stereotaxis (STXS), Rockwell Medical (RMTI), Soleno Therapeutics (SLNO), Fonar (FONR), BioSig Technologies (BSGM), Second Sight Medical Products (EYES), IRIDEX (IRIX), Fc Global Realty (FCRE) and electroCore (ECOR).

Based on aggregate information from My MarketBeat watchlists, some companies that other Edap Tms investors own include Energous (WATT), Weatherford International (WFT), CTI BioPharma (CTIC), PETROLEO BRASIL/ADR (PBR), Kandi Technologies Group (KNDI), Misonix (MSON), Achillion Pharmaceuticals (ACHN), Advanced Micro Devices (AMD), Destination Maternity (DEST) and Pacific Drilling (PACDQ).

Edap Tms' stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Archon Capital Management LLC (1.86%), Acadian Asset Management LLC (0.53%), Accredited Investors Inc. (0.51%), Fosun International Ltd (0.38%), California Public Employees Retirement System (0.17%) and New York State Common Retirement Fund (0.11%).

EDAP stock was sold by a variety of institutional investors in the last quarter, including Fosun International Ltd, Acadian Asset Management LLC, Archon Capital Management LLC, Bank of America Corp DE and New York State Common Retirement Fund.

EDAP stock was purchased by a variety of institutional investors in the last quarter, including Accredited Investors Inc., Virtu Financial LLC and California Public Employees Retirement System.

Shares of EDAP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of EDAP stock can currently be purchased for approximately $4.35.

Edap Tms has a market capitalization of $126.14 million and generates $46.17 million in revenue each year. The medical equipment provider earns $-400,000.00 in net income (profit) each year or $0.02 on an earnings per share basis. Edap Tms employs 215 workers across the globe.View Additional Information About Edap Tms.

The official website for Edap Tms is http://www.edap-tms.com/.

Edap Tms' mailing address is Parc d'Activites la Poudrette-Lamartine 4/6 rue du Dauphine, Vaulx-en-Velin I0, 69120. The medical equipment provider can be reached via phone at 33-04-72-15-31-50 or via email at [email protected]